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P R E V I E W SThe molecular genetics of the melanocortin
pathway and energy homeostasis
The CNS melanocortin pathway plays an important role in the control of body weight. Two papers in this issue of Cell
Metabolism, Lee et al., 2006 and Biebermann et al., 2006, suggest that b MSH—a product of POMC processing—plays an
unanticipated role in this pathway in humans.‘‘The proper study of mankind is
man’’ A. Pope, Essay on Man
(1733–1734)
Considerable evidence supports a
strong genetic basis for human predispo-
sition to obesity. This includes twin and
adoption studies (Maes et al., 1997), as
well as identification of statistically linked
genetic intervals or alleles of specific
candidate genes. In seeming contradis-
tinction to such data, the prevalence of
obesity is increasing rapidly in many
parts of the world, at a pace that cannot
possibly be accounted for by changes
in allele frequencies of relevant genes in
these populations (Flegal et al., 2002).
The most likely explanation for these out-
wardly disparate observations is that hu-
mans segregating for alleles selected by
evolution to enhance energy storage
and reproductive efficiency have, by vir-
tue of more recently selected enhance-
ments in higher cortical function, suc-
ceeded in creating an environment in
which such metabolic efficiency is actu-
ally a disadvantage. The search for ge-
netic factors takes a step forward in this
issue of Cell Metabolism, with two pa-
pers demonstrating that b MSH, a small
peptide cleaved from proopiomelano-
cortin (POMC) in humans, but not in ro-
dents, plays a role in the control of body
weight in humans.
Rodent studies identified the melano-
cortin pathway as an important compo-
nent in the control of body weight. The
melanocortin pathway conveys primarily
anorexigenic signals in the hypothalamus
and brain stem via receptors (MC4R,
MC3R) thatmediate the effects of ligands
generated by the posttranslational pro-
cessing of POMC by proconvertases
(PC1 + PC2) and other peptidases. Mod-
ifiers of the action of the POMC-derived
ligands at these receptors include attrac-
tin, (ATRN), mahogunin (MGRN1), AgRP,
and ASP. The critical role of the melano-
cortin system in the control of energy ho-
meostasis is reflected in the obesity of
animals and/or humans with null or hypo-CELL METABOLISM : FEBRUARY 2006morphic alleles of POMC,MC4R,MC3R,
or the relevant proconvertase processing
enzymes (Cone, 2005).
The causal relationship of inactivating
POMC mutations to obesity was identi-
fied first in humans (Krude et al., 1998);
mice with knockouts of Pomc were cre-
ated subsequently to enable mechanistic
studies. Based upon the phenotypes of
humans and mice with these mutations,
and the absence in rodents of an endo-
nuclease site that allows PC2 to cleave
the 18 aa b MSH from its POMC precur-
sor, it was generally assumed that the
obesity associated with hetero- or homo-
zygosity for inactivating mutations of
POMC was due to lack of a MSH, a po-
tent MC3/4R agonist and suppressor of
food intake (Figure 1). Two papers in
this issue of Cell Metabolism suggest
that this inference was wrong, or at least
incomplete. Humans heterozygous for
a rare Y5C variant in b MSH (Tyr221CyS
in POMC) (demonstrated in vitro to dis-
play significantly reduced binding and
activation of MC4R) are shown here to
be at increased risk of obesity.
POMC is expressed in the hypothala-
mus, pituitary, and skin (including hair
follicle) where posttranslational process-
ing of the 241 aa protein (in humans) by
proconvertases 1, 2 (acting as endopep-
tidases at adjacent combinations of di-
basic amino acids Lys and Arg) (Seidah
and Chretien, 1994) generates ACTH,
melanocortins, and b endorphins in or-
gan-specific fashion (Figure 1). The levels
of these endopeptidases decrease with
fasting and increase with administration
of leptin, accounting for some of the
changes seen in POMC production in
these circumstances. The specific ef-
fects of aMSH (a 13 aa cleavage product
of ACTH precursor in the hypothalamus
and hair follicle) on energy homeostasis
and skin/hair pigment (via MC1R) are
widely acknowledged. aMSH is a potent
anorectic peptide acting through MC4R
and, possibly MC3R, in the regions of
the brain receiving POMC neuron projec-tions. g MSH (from the N-terminal frag-
ment of POMC) acts via MC3R to influ-
ence blood pressure and natriuresis.
The physiological role of b MSH (an 18
aa product of C-terminal b LPH) is less
clear. b MSH is anorexigenic when ap-
plied ICV to rats, but this endopeptide is
not synthesized to any significant extent
in rodent hypothalamus due to the fact
that the mouse and rat lack a canonical
endopeptidase site at amino acids 215/
216 of POMC (http://www.pir.uniprot.
org/); this is the site before the amino ter-
minus of b MSH in humans.
In the brain, POMC is most highly ex-
pressed in the arcuate nucleus of the hy-
pothalamus and the solitary tract (NTS) of
the brain stem. The arcuate POMC neu-
rons send projections widely throughout
the brain including the paraventricular
nucleus (PVN), lateral hypothalamus,
amygdala, and reticular nucleus. These
neurons have the molecular machinery
to integrate signals from leptin, NPY,
melanocortins, serotonin, CCK, Ghrelin,
PPY, and circulating nutrients (e.g., glu-
cose) (Cone, 2005).
Codominant mutations of MC4R may
account for about 5% of early-onset, se-
vere obesity in humans, and KO mice
show similar genetics and phenotypes
(Farooqi et al., 2003). It has been gener-
ally assumed that the metabolic pheno-
types in both humans and rodents are
due primarily to reduced a MSH signal-
ing. In humans and mice, homozygosity
for effectively null alleles of POMC results
in severe obesity, adrenal insufficiency,
and lightened skin/hair pigmentation,
while heterozygosity appears to moder-
ately increase obesity proneness in both
mice and humans without causing adre-
nal insufficiency or pigment changes.
Notably, interruption of the melanocorti-
nergic system at either POMC or MC4R
results not only in obesity due to both in-
creased energy intake and reduced en-
ergy expenditure, but also increased lin-
ear growth, lean body mass, and bone
mineral density (Farooqi et al., 2003).79
P R E V I E W SFigure 1. Production and actions of melanocortins in cell bodies
Proopiomelanocortin (POMC) is differentially processed in the pituitary and hypothalamus due to differential
expression of two endopeptidases, PC1(PC1/3) and PC2. The pituitary expresses PC1, the hypothalamus ex-
presses PC1 and PC2. a and b MSH—produced by the actions of PC2 on ACTH and g LPH, respectively, in
the arcuate and NTS—act via G protein-coupled receptors (MC4R, MC3R) in the LH, amygdale, and elsewhere
to reduce energy intake and increase energy expenditure. The endonuclease site* (amino acids 215/216 of
POMC) that allows PC2 to cleave b MSH from g LPH is absent in rodents, present in humans. Abbreviations
are as follows: ARC, arcuate nucleus; NTS, nucleus of solitary tract; PVN, paraventricular nucleus; LH, lateral
hypothalamus; MCR, melanocortin receptor.In Mc4r2/2 mice, the primary mecha-
nism for obesity (of relatively late onset
compared to affected humans) is in-
creased energy intake. However, female
mice show evidence of reduced energy
expenditure, and males show reduced lo-
comotor activity (Ste Marie et al., 2000). It
is not clear that effects onenergyexpendi-
ture/physical activity play a significant role
in humans with hypomorphic MC4R al-
leles. The six Tyr221Cys b MSH hetero-
zygotes studied by Lee et al. (2006) in a
clinical research center showed marked
increases inenergy intakebutnodecrease
in resting metabolic rate. In the two fami-
lies reported by Biebermann et al. (2006),
the proband children have the highest
BMI deviations in the family, but the sever-
ity of obesity in affected older familymem-
bers is less.The same reduction inseverity
of obesity with age has been reported in
humans with hypomorphicMC4R alleles.
Challis et al. (2002) described a human
subject in whom obesity was associated
with a mutation producing a fusion pro-
tein of b MSH/b endorphin. It was not
clear whether the obesity in this individ-
ual reflected a dominant-negative effect
of the fusion protein on a MSH activity
at MC3/4R and/or an effect of bMSH hy-
pofunction (Challis et al., 2002). The two80papers in the current issue ofCell Metab-
olism suggest that b MSH itself plays a
role in the control of energy homeostasis
in humans. Interestingly, the phenotype
of the affected children included acceler-
ated linear growth and increased fat-free
massalso seen, as notedabove, in POMC-
and MC4R-deficient humans and mice.
None of the previously reported POMC
mutations would be predicted to pre-
serve b MSH synthesis while eliminating
aMSH. Hence, onemight expect individ-
uals with the nominally b-MSH-only inac-
tivation described in these two papers to
display less severe obesity than individ-
uals heterozygous for a POMC allele af-
fecting both a and b MSH quantity and/
or function. Clearly, the (presumed) pres-
ervation of a MSH synthesis in the re-
ported b MSH hypomorphs does not
‘‘rescue’’ the obese phenotype. A related
question is: Why in obligate POMC null
heterozygotes, is the degree of obesity
not equal to or greater than that of the
b MSH-only subjects? The greater effect
of the Try221Cys b MSH mutation sug-
gests, contrary to the in vitro evidence
against a dominant-negative effect of
this mutation, that just such a phenome-
non may be occurring in vivo, possibly
due to further processing of the aberrantpeptides created by the mutation. A
mouse with a humanized Pomc gene
segregating for this mutation could help
to answer some of these questions.
Finally, MC3R mediates lordosis re-
sponses in rodent females, and MC4R
activation stimulates erectile function
in male rodents and humans. Strikingly
absent from reports on the phenotypes
of individuals with MC3R, MC4R, and
POMC mutations is mention of possible
effects on these aspects of neurophysiol-
ogy. Clearly, mutation-specific effects on
these phenotypes would be of consider-
able interest.
What is the take home message from
these papers? That, in the study of the
molecular physiology of human energy
homeostasis (and most other human
phenotypes for that matter), the circum-
spect analysis of carefully selected hu-
man subjects can reveal processes/
mechanisms not discoverable (or even
present) in an experimental animal. In
the instance discussed here, onemissing
endopeptidase site (in rodents) appar-
ently alters important aspects of the mo-
lecular physiology of a critical pathway in
the control of energy homeostasis. Alex-
ander Pope – an acerbic investigator of
the human condition – got it right. So
did these investigators.
Rudolph L. Leibel1
1Columbia University
Division of Molecular Genetics
and Naomi Berrie Diabetes Center
1150 St. Nicholas Avenue
Room 620
New York, New York 10032
Selected reading
Biebermann, H., Castan˜eda, T.R., van Lande-
ghem, F., von Deimling, A., Escher, F., Brabant,
G., Hebebrand, J., Hinney, A., Tscho¨p, M.H.,
Gru¨ters, A., et al. (2006). Cell Metab. 3, this issue,
141–146.
Challis, B.G., Pritchard, L.E., Creemers, J.W.,
Delplanque, J., Keogh, J.M., Luan, J., Wareham,
N.J., Yeo, G.S., Bhattacharyya, S., Froguel, P.,
et al. (2002). Hum. Mol. Genet. 11, 1997–2004.
Cone, R.D. (2005). Nat. Neurosci. 8, 571–578.
Farooqi, I.S., Keogh, J.M., Yeo, G.S., Lank, E.J.,
Cheetham, T., and O’Rahilly, S. (2003). N. Engl.
J. Med. 348, 1085–1095.
Flegal, K.M., Carroll, M.D., Ogden, C.L., and
Johnson, C.L. (2002). JAMA 288, 1723–1727.
Krude, H., Biebermann, H., Luck, W., Horn, R.,
Brabant, G., and Gruters, A. (1998). Nat. Genet.
19, 155–157.CELL METABOLISM : FEBRUARY 2006
P R E V I E W SLee, Y.S., Challis, B.G., Thompson, D.A.,
Yeo, G.S.H., Keogh, J.M., Madonna, M.E.,
Wraight, V., Sims, M., Vatin, V., Meyre, D.,
et al. (2006). Cell Metab. 3, this issue, 135–
140.Unlikely partners in w
The classic role of bile acids is as a k
Nature (Watanabe et al., 2006), however,
induction of thyroid hormone signaling
regulation.
Maintenance of normal serum choles-
terol levels is essential for life. Excess
cholesterol is eliminated by hepatic con-
version to soluble bile acids (BAs), which
are excreted into the small intestine.
Most of the BA pool, however, is subse-
quently reabsorbedand recycled through
the enterohepatic circulation. The pro-
duction of BAs from cholesterol is regu-
lated by the farnesoid X receptor (FXR),
which when bound by BAs ultimately
reduces expression of cholesterol 7 a-
hydroxylase, the rate-limiting enzyme in
BA synthesis (for review, see Kalaany
and Mangelsdorf [2005]).
In addition to acting through this clas-
sic nuclear hormone signaling pathway,
BAs have also been shown to signal in
an FXR-independent manner by binding
to a novel G protein-coupled cell-surface
receptor, termed TGR5 (Maruyama et al.,
2002). Activation of TGR5 leads to in-
creased intracellular cAMP production,
which modifies macrophage function
(Kawamata et al., 2003). Now a landmark
paper recently published in Nature by
Watanabe et al. (2006) describes an
FXR-independent role for BAs in control-
ling energy expenditure (EE). The authors
demonstrate that BAs increase EE in
brown adipose tissue of mice, resulting
in prevention of diet-induced obesity
and insulin resistance. Based on in vitro
studies in human skeletal myocytes,
they postulate that bile acids would also
increase EE in man.
The novel role for BAs in regulating cel-
lular metabolism as described by Wata-
nabe et al. (2006) is illustrated in Figure 1.
BAs bind to the TGR5 receptor (coupled
to Gs), which leads to increased intracel-
lular cAMP production and induction of
the Dio2 gene whose gene product is
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ey component of cholesterol homeostasi
describes a bile acid signaling pathway th
pathways. This work may point to new ap
type 2 iodothyronine deiodinase or D2.
Several major BAs such as cholic acid,
deoxycholic acid, and chenodeoxycholic
acid activate this pathway, but a syn-
thetic FXR agonist, GW4064, has no ef-
fect. BAs induce D2 expression in ther-
mogenically important tissues such as
murine brown fat and human skeletal my-
ocytes, because only these tissues ex-
press both TGR5 and D2. D2 then con-
verts locally available T4 to T3, without
leading to an increase in circulating thy-
roid hormone levels, resulting in an in-
crease in oxygen consumption and EE.
In addition to D2, several genes involved
in EE were increased in brown adipose
tissue after BA treatment: peroxisome
proliferator-activated receptor g coacti-
vator-1a and -1b, uncoupling protein
(UCP) 1 and 3, straight chain acyl-CoA
oxidase 1, and muscle carnitine palmi-
toyltransferase. The increase in D2 ex-
pression, however, is essential for the in-
crease in EE by BAs, since diet-induced
obesity is prevented in wild-type but not
D2 knockout mice after BA treatment.
A high-fat diet also increases D2 ex-
pression in brown adipose tissue, but
this effect appears to be downstream
from TGR5 (see Figure 1), since cAMP
levels are not increased to the same ex-
tent as D2 levels by this diet. BAs in-
crease cAMP and D2 levels in brown ad-
ipose tissue, but these effects are much
more pronounced in tissue obtained
from mice fed a high-fat diet rather than
fed a regular diet. The authors point out
that this might explain why BAs prevent
diet-induced obesity but do not affect
the bodyweight of animals fed a regular
diet. Thus, the BA effect is specific to
thermogenic tissues and is observed
only when mice are fed a high-fat diet.Ste Marie, L., Miura, G.I., Marsh, D.J., Yagaloff,
K., and Palmiter, R.D. (2000). Proc. Natl. Acad.
Sci. USA 97, 12339–12344.
DOI 10.1016/j.cmet.2006.01.010s. New evidence recently published in
at controls energy expenditure through
proaches to tissue-specific metabolic
Exactly how T3, produced locally by
D2, mediates an increase in oxygen con-
sumption and EE in murine brown adi-
pose tissue or human skeletal muscle re-
mains to be clarified. One potential
mechanism is T3-mediated induction of
UCP expression. UCPs dissipate the
proton gradient generated by the elec-
tron transport chain as heat resulting in
a reduction in ATP synthesis. Since
both T3 and cAMP are known to increase
expression of UCP1 in brown adipose
tissue (Ribeiro et al., 2001), this could
potentially explain the increase in EE ob-
served in mice treated with BAs. In con-
trast, fat-free body mass, which is pre-
dominantly skeletal muscle, is the major
determinant of basal metabolism in
humans, which lack significant amounts
of brown adipose tissue (except in the
neonatal period; Ravussin et al., 1986).
Importantly, skeletal muscle UCP3 ex-
pression is positively correlated with EE
in the Pima Indians, increased by T3,
and decreased in type 2 diabetics (for
review, see Hesselink and Schrauwen
[2005]). Thus like UCP1, UCP3 induction
in skeletal muscle might mediate an in-
crease in EE in humans after BA treat-
ment promoting weight loss and insulin
sensitivity.
The mechanism(s) by which BAs in-
crease EE, however, is likely to be more
complex than noted above. For example,
in the 1930s, patients given the artificial
uncoupler of oxidative phosphorylation,
2,4 dinitrophenol (DNP), at low to mod-
erate doses demonstrated significant
weight loss without associated increases
in urinary nitrogen excretion or heart rate
(for review, see Harper et al. [2001]).
Higher doses of DNP, in contrast, were
associated with cataract formation and
81
